Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kelly

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Stroke|September 9, 2021
StrokeCog Markov Model: Projected Prevalent and Incident Cases of Stroke and Poststroke Cognitive Impairment to 2035 in IrelandEithne Sexton, Nora-Ann Donnelly, Niamh A Merriman, et al.
BMJ Open|July 22, 2020
Cohort profile: BIOVASC-late, a prospective multicentred study of imaging and blood biomarkers of carotid plaque inflammation and risk of late vascular recurrence after non-severe stroke in IrelandJohn Joseph McCabe, Nicola Giannotti, Jonathan McNulty, et al.
International Journal of Cardiology|May 2, 2024
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe studyPaulus Kirchhof, Ameet Bakhai, Carlo de Asmundis, et al.
Irish Journal of Medical Science|June 21, 2020
Moyamoya disease and moyamoya syndrome in Ireland: patient demographics, mode of presentation and outcomes of EC-IC bypass surgeryRonan J Doherty, John Caird, Darach Crimmins, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 13, 2018
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) studyRaffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
European Stroke Journal|July 11, 2023
Delivery of acute ischaemic stroke treatments in the European region in 2019 and 2020Diana Aguiar de Sousa, Arlene Wilkie, Bo Norrving, et al.
European Heart Journal|March 26, 2021
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trialsAernoud T L Fiolet, Tjerk S J Opstal, Arend Mosterd, et al.
Journal of Child & Adolescent Trauma|August 18, 2023
Trauma Informed Interventions to Reduce Seclusion, Restraint and Restrictive Practices Amongst Staff Caring for Children and Adolescents with Challenging Behaviours: A Systematic ReviewPeter Kelly, Mohamad M Saab, Emma J Hurley, et al.
BMC Cardiovascular Disorders|July 14, 2019
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Raffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical carePaulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Stroke|September 9, 2021
StrokeCog Markov Model: Projected Prevalent and Incident Cases of Stroke and Poststroke Cognitive Impairment to 2035 in IrelandEithne Sexton, Nora-Ann Donnelly, Niamh A Merriman, et al.
BMJ Open|July 22, 2020
Cohort profile: BIOVASC-late, a prospective multicentred study of imaging and blood biomarkers of carotid plaque inflammation and risk of late vascular recurrence after non-severe stroke in IrelandJohn Joseph McCabe, Nicola Giannotti, Jonathan McNulty, et al.
International Journal of Cardiology|May 2, 2024
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe studyPaulus Kirchhof, Ameet Bakhai, Carlo de Asmundis, et al.
Irish Journal of Medical Science|June 21, 2020
Moyamoya disease and moyamoya syndrome in Ireland: patient demographics, mode of presentation and outcomes of EC-IC bypass surgeryRonan J Doherty, John Caird, Darach Crimmins, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 13, 2018
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) studyRaffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
European Stroke Journal|July 11, 2023
Delivery of acute ischaemic stroke treatments in the European region in 2019 and 2020Diana Aguiar de Sousa, Arlene Wilkie, Bo Norrving, et al.
European Heart Journal|March 26, 2021
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trialsAernoud T L Fiolet, Tjerk S J Opstal, Arend Mosterd, et al.
Journal of Child & Adolescent Trauma|August 18, 2023
Trauma Informed Interventions to Reduce Seclusion, Restraint and Restrictive Practices Amongst Staff Caring for Children and Adolescents with Challenging Behaviours: A Systematic ReviewPeter Kelly, Mohamad M Saab, Emma J Hurley, et al.
BMC Cardiovascular Disorders|July 14, 2019
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Raffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical carePaulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
Pageof 13